Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
January 17, 2019
They make semiconductor equipment, but not semiconductors. He thinks an inventory drag will get worked out in the second quarter. It is a good buying opportunity.
Show full opinionHide full opinion
Applied Materials (AMAT-Q)
January 17, 2019
They make semiconductor equipment, but not semiconductors. He thinks an inventory drag will get worked out in the second quarter. It is a good buying opportunity.
BUY WEAKNESS
BUY WEAKNESS
January 17, 2019
They are more into cedar and it is not a commodity. A slowdown in the economy will cause reduced cedar usage. In the $2 range it is very attractive.
Show full opinionHide full opinion
They are more into cedar and it is not a commodity. A slowdown in the economy will cause reduced cedar usage. In the $2 range it is very attractive.
BUY
BUY
January 17, 2019
He is encouraged by the new CEO's moves in the last year. They get a good chunk of earnings form wealth management in Asia. He could potentially add to it in the future.
Show full opinionHide full opinion
Manulife Financial (MFC-T)
January 17, 2019
He is encouraged by the new CEO's moves in the last year. They get a good chunk of earnings form wealth management in Asia. He could potentially add to it in the future.
TOP PICK
TOP PICK
January 17, 2019
The oldest manufacturer of syringes and other medical devices. There is good growth in emerging countries. They will pay down debt and have attractive dividend growth. (Analysts’ price target is $263.10)
Show full opinionHide full opinion
Becton Dickinson (BDX-N)
January 17, 2019
The oldest manufacturer of syringes and other medical devices. There is good growth in emerging countries. They will pay down debt and have attractive dividend growth. (Analysts’ price target is $263.10)
TOP PICK
TOP PICK
January 17, 2019
They have good growth opportunities in BC and Arizona. Over 45 years they have raised their dividend. 16 times earnings. A well managed company. If there is more volatility this is a good place to be. (Analysts’ price target is $48.20)
Show full opinionHide full opinion
Fortis Inc. (FTS-T)
January 17, 2019
They have good growth opportunities in BC and Arizona. Over 45 years they have raised their dividend. 16 times earnings. A well managed company. If there is more volatility this is a good place to be. (Analysts’ price target is $48.20)
TOP PICK
TOP PICK
January 17, 2019
It has lagged the banking group. In 2018 they were busy doing acquisitions in south America. They have a good focus on costs. They will integrate their acquisitions. This is a good time to get in. (Analysts’ price target is $81.78)
Show full opinionHide full opinion
It has lagged the banking group. In 2018 they were busy doing acquisitions in south America. They have a good focus on costs. They will integrate their acquisitions. This is a good time to get in. (Analysts’ price target is $81.78)